Medotramol

Tramadol Hydrochloride and Paracetamol, the active ingredients in Medotramol, are analgesics presented as an oral tablet for oral use. They provide pain relief for moderate to severe acute and chronic pain in adult patients, combining opioid‑type activity with central COX inhibition. GNH USA supplies Medotramol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medotramol is indicated for pain management across several clinical settings. - Acute postoperative pain: reduces pain intensity after surgical procedures. - Musculoskeletal pain: alleviates pain from injuries or inflammatory conditions. - Cancer‑related pain: provides supplemental relief for breakthrough pain in oncology patients.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: transient light‑headedness. - Constipation: reduced bowel movements. - Headache: occasional throbbing pain. - Somnolence: feeling unusually sleepy. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Seizures: risk increased at high doses or with interacting drugs. - Respiratory depression: slowed breathing, especially with CNS depressants. - Allergic reactions: rash, itching, or swelling. - Serotonin syndrome: agitation, hyperthermia, or tremor when combined with serotonergic agents. - Hepatotoxicity: rare liver injury with prolonged use.

When prescribing Medotramol, consider the following precautions. - Renal function assessment: adjust use in patients with impaired kidney function. - Hepatic function evaluation: monitor liver enzymes in patients with liver disease. - Seizure history: use cautiously in individuals with a history of seizures. - Concomitant CNS depressants: avoid or reduce dose when combined with alcohol, benzodiazepines, or other sedatives. - Serotonin syndrome risk: review concurrent serotonergic medications. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Medotramol may interact with several drug classes. Major Interactions (Avoid): - MAO inhibitors: risk of severe serotonin syndrome. - SSRIs/SNRIs: increased serotonin toxicity. - Alcohol or other CNS depressants: enhanced sedation and respiratory depression. Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect. - CYP2D6 inhibitors (e.g., fluoxetine): may increase tramadol plasma levels.